Sectors

WAT
Waters Corporation
377.04
1 x 377.12
1 x 377.45
bid
ask
+
3.82
1.02%
02:32 PM
timesize
Ytd-0.73%
1y23.95%
368.92
day range
377.14
277.72
52 week range
412.54
Open371.49Prev Close373.22Low368.92High377.14Mkt Cap24.33B
Vol321.09KAvg Vol1.03MEPS13.58P/E27.48Forward P/E22.82
Beta1.20Short Ratio3.72Inst. Own99.72%DividendN/ADiv YieldN/A
Ex Div Date11-26Earning08-0450-d Avg355.11200-d Avg349.811yr Est407.13
Earning
DateForEstimateReportedSurprisesurprise %
2026-05-052026-032.312.70.3916.88%
2026-02-092025-124.54.530.030.67%
2025-11-042025-093.213.40.195.92%
2025-08-042025-062.932.950.020.68%
2025-05-062025-032.222.250.031.35%
2025-02-122024-124.024.10.081.99%
Upgrade / Downgrade
DateFirmActionFromTo
2026-07-09Morgan StanleyUpgradeEqual-WeightEqual-Weight
2026-07-09RBC CapitalUpgradeOutperform
2026-07-08GuggenheimUpgradeBuyBuy
2026-07-06Evercore ISI GroupUpgradeOutperformOutperform
2026-06-11Piper SandlerUpgradeNeutral
2026-06-03HSBCUpgradeBuyBuy
Profile
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. The company operates through two segments, Waters and TA. The company designs, manufactures, sells, and services liquid chromatography, as well as mass spectrometry (MS) technology systems and supports products, including chromatography columns, and other consumable products. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer goods, and healthcare products, as well as for life science research; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology, which is used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.
Insider Holder
DateNameRelationQuantityDescription
2026-02-24BATRA UDITChief Executive Officer36.56KStock Award(Grant)
2026-02-24BENNETT JIANQINGOfficer7.24KStock Award(Grant)
2026-02-24CARPIO ROBERT L IIIOfficer3.62KStock Award(Grant)
2026-02-24CHAUBAL AMOLChief Financial Officer8.51KStock Award(Grant)
2026-03-05FEARON RICHARD HDirector3.30KPurchase
2026-02-24HUANG PEARL S.Director3.28KStock Award(Grant)
Institution Ownership
Report DateOrganizationPositionValuePercentage
2026-03-30Blackrock Inc.8.54M3.22B8.70%
2026-03-30Vanguard Capital Management LLC6.38M2.40B6.50%
2026-03-30Vanguard Portfolio Management LLC4.75M1.79B4.84%
2026-03-30T. Rowe Price Investment Management, Inc.4.66M1.76B4.75%
2026-03-30Massachusetts Financial Services Co.4.63M1.74B4.72%
2026-03-30State Street Corporation4.36M1.64B4.44%
Fund Ownership
Report DateOrganizationPositionValuePercentage
2026-03-30VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund3.12M1.17B3.18%
2026-03-30T. ROWE PRICE CAPITAL APPRECIATION Fd., INC.-T. Rowe Price Capital App2.75M1.03B2.80%
2026-03-30VANGUARD INDEX FUNDS-Vanguard 500 Index Fund2.49M938.56M2.54%
2026-03-30VANGUARD INDEX FUNDS-Vanguard Mid-Cap Index Fund2.12M797.52M2.16%
2026-05-30iShares Trust-iShares Core S&P 500 ETF1.29M486.37M1.32%
2026-05-30Fidelity Concord Street Trust-Fidelity 500 Index Fund1.26M472.45M1.28%
Dividend
DividendDate
0.161996-11-26
Split
SplitDate
2 : 12000-08-28
2 : 11999-06-11